Topco Extra Strength Gas Relief Tablets

Manufacturer
Topco Associates, LLC | Guardian Drug Company
Effective date
2024-12-26
Label type
Human OTC Drug Label
Version
2
Source
full-release
Hydrated at
2026-06-01 00:49:18

Label at a glance#

ProductGas Relief
Active ingredientDIMETHICONE
Label structure9 sections

Dosage and administration

chew 1 to 2 tablets thoroughly as needed after meals and at bedtime do not exceed 4 tablets in a 24 hour period except under the advice and supervision of  a physician

Storage and handling

do not use if any individual blister unit is broken or open store at room temperature avoid high humidity and excessive heat, above 40ºC (104ºF)

Label contents#

Full prescribing information#

ACTIVE INGREDIENT(in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Simethicone 125 mg

PURPOSE

OTC - PURPOSE SECTION

Anti-gas

USE(S)

INDICATIONS & USAGE SECTION

relieves:

  • pressure
  • bloating
  • symptoms referred to as gas

WARNINGS

WARNINGS SECTION

.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a poison control center immediately.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • chew 1 to 2 tablets thoroughly as needed after meals and at bedtime
  • do not exceed 4 tablets in a 24 hour period except under the advice and supervision of  a physician

OTHER INFORMATION

STORAGE AND HANDLING SECTION

  • do not use if any individual blister unit is broken or open
  • store at room temperature
  • avoid high humidity and excessive heat, above 40ºC (104ºF)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

D&C red # 30 aluminum lake, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucrose

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Topcare
NDC 36800-122-73
COMPARE TO GAS-X® EXTRA STRENGTH ACTIVE INGREDIENT*
EXTRA STRENGTH
Gas
Relief

ANTI-GAS/SIMETHICONE, 125 mg

FAST RELIEF OF:

  • Bloating
  • Pressure
  • Discomfort of Gas

CHERRY FLAVOR

18 CHEWABLE TABLETS

7575

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
314221simethicone 125 MG Chewable TabletPSN2
314221simethicone 125 MG Chewable TabletSCD2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DIMETHICONE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
36800-122-73Gas Relief3 in 1 CARTONTABLET, CHEWABLE32
36800-122-73Gas Relief6 in 1 BLISTER PACKTABLET, CHEWABLE62

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
36800-122GAS RELIEF (SIMETHICONE) TABLET, CHEWABLE [TOPCO ASSOCIATES, LLC]2Current NDC, Legacy NDC, 2 package rows20241228_c90d68a0-22e1-4a37-8487-16ecdc431ede.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
36800-12236800-122-73

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gas ReliefSIMETHICONETopco Associates, LLCc90d68a0-22e1-4a37-8487-16ecdc431ede2024-12-26WarningsExact identifier
ndc (package): 36800-122-73
ndc (product): 36800-122
ndc11 (package): 36800012273
spl id: 060e2eb9-d8f8-448f-8db4-928ebac288a9
spl set id: c90d68a0-22e1-4a37-8487-16ecdc431ede

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.